210 related articles for article (PubMed ID: 9361395)
21. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
Laplante Y; Cadot C; Fournier MA; Poirier D
Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer.
Duncan L; Purohit A; Howarth NM; Potter BV; Reed MJ
Cancer Res; 1993 Jan; 53(2):298-303. PubMed ID: 8417823
[TBL] [Abstract][Full Text] [Related]
23. 17 beta-hydroxysteroid oxidoreductase activity in intact cells significantly differs from classical enzymology analysis.
Castagnetta LA; Granata OM; Taibi G; Lo Casto M; Comito L; Oliveri G; Di Falco M; Carruba G
J Endocrinol; 1996 Sep; 150 Suppl():S73-8. PubMed ID: 8943790
[TBL] [Abstract][Full Text] [Related]
24. Effect of tibolone (Org OD14) and its metabolites on aromatase and estrone sulfatase activity in human breast adipose stromal cells and in MCF-7 and T47D breast cancer cells.
van de Ven J; Donker GH; Sprong M; Blankenstein MA; Thijssen JH
J Steroid Biochem Mol Biol; 2002 Jul; 81(3):237-47. PubMed ID: 12163135
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of oestrone sulphatase activity by tibolone and its metabolites.
Purohit A; Malini B; Hooymans C; Newman SP
Horm Metab Res; 2002 Jan; 34(1):1-6. PubMed ID: 11832993
[TBL] [Abstract][Full Text] [Related]
26. The SEEM: selective estrogen enzyme modulators in breast cancer.
Pasqualini JR; Ebert C; Chetrite GS
Gynecol Endocrinol; 1999 Dec; 13 Suppl 6():1-8. PubMed ID: 10862262
[TBL] [Abstract][Full Text] [Related]
27. Effects of hormone therapy on estrogen synthesis from E1S in the mammary gland of postmenopausal women.
Stute P; Szuwart T; Schlueter M; Götte M; Packeisen J; Kiesel L
Maturitas; 2008 Feb; 59(2):163-73. PubMed ID: 18261865
[TBL] [Abstract][Full Text] [Related]
28. Relative involvement of three 17beta-hydroxysteroid dehydrogenases (types 1, 7 and 12) in the formation of estradiol in various breast cancer cell lines using selective inhibitors.
Laplante Y; Rancourt C; Poirier D
Mol Cell Endocrinol; 2009 Mar; 301(1-2):146-53. PubMed ID: 18812208
[TBL] [Abstract][Full Text] [Related]
29. The selective estrogen enzyme modulator (SEEM) in breast cancer.
Chetrite GS; Pasqualini JR
J Steroid Biochem Mol Biol; 2001; 76(1-5):95-104. PubMed ID: 11384867
[TBL] [Abstract][Full Text] [Related]
30. Recent data on estrogen sulfatases and sulfotransferases activities in human breast cancer.
Pasqualini JR; Schatz B; Varin C; Nguyen BL
J Steroid Biochem Mol Biol; 1992 Mar; 41(3-8):323-9. PubMed ID: 1580921
[TBL] [Abstract][Full Text] [Related]
31. Estrone sulfatase versus estrone sulfotransferase in human breast cancer: potential clinical applications.
Pasqualini JR; Chetrite GS
J Steroid Biochem Mol Biol; 1999; 69(1-6):287-92. PubMed ID: 10419004
[TBL] [Abstract][Full Text] [Related]
32. Androgen receptor-mediated stimulation of 17 beta-hydroxysteroid dehydrogenase activity by dihydrotestosterone and medroxyprogesterone acetate in ZR-75-1 human breast cancer cells.
Couture P; Thériault C; Simard J; Labrie F
Endocrinology; 1993 Jan; 132(1):179-85. PubMed ID: 8380373
[TBL] [Abstract][Full Text] [Related]
33. Estradiol inhibits the estrone sulfatase activity in normal and cancerous human breast tissues.
Chetrite GS; Cortes-Prieto JC; Philippe JC; Pasqualini JR
J Steroid Biochem Mol Biol; 2007 May; 104(3-5):289-92. PubMed ID: 17481887
[TBL] [Abstract][Full Text] [Related]
34. Biological effects of progestins in breast cancer.
Pasqualini JR; Ebert C
Gynecol Endocrinol; 1999 Jun; 13 Suppl 4():11-9. PubMed ID: 12227897
[TBL] [Abstract][Full Text] [Related]
35. Differential effects of progestogens, by type and regimen, on estrogen-metabolizing enzymes in human breast cancer cells.
Xu B; Kitawaki J; Koshiba H; Ishihara H; Kiyomizu M; Teramoto M; Kitaoka Y; Honjo H
Maturitas; 2007 Feb; 56(2):142-52. PubMed ID: 16962266
[TBL] [Abstract][Full Text] [Related]
36. Action of danazol on the conversion of estrone sulfate to estradiol and on the sulfatase activity in the MCF-7, T-47D and MDA-MB-231 human mammary cancer cells.
Nguyen BL; Ferme I; Chetrite G; Pasqualini JR
J Steroid Biochem Mol Biol; 1993 Jul; 46(1):17-23. PubMed ID: 8338787
[TBL] [Abstract][Full Text] [Related]
37. Oxidations of 17beta-estradiol and estrone and their interconversions catalyzed by liver, mammary gland and mammary tumor after acute and chronic treatment of rats with indole-3-carbinol or beta-naphthoflavone.
Ritter CL; Prigge WF; Reichert MA; Malejka-Giganti D
Can J Physiol Pharmacol; 2001 Jun; 79(6):519-32. PubMed ID: 11430590
[TBL] [Abstract][Full Text] [Related]
38. Estradiol 17 beta-hydroxysteroid dehydrogenase, a marker of breast cancer hormone dependency.
Fournier S; Brihmat F; Durand JC; Sterkers N; Martin PM; Kuttenn F; Mauvais-Jarvis P
Cancer Res; 1985 Jun; 45(6):2895-9. PubMed ID: 3857123
[TBL] [Abstract][Full Text] [Related]
39. Selective estrogen enzyme modulator actions of melatonin in human breast cancer cells.
Gonzalez A; Cos S; Martinez-Campa C; Alonso-Gonzalez C; Sanchez-Mateos S; Mediavilla MD; Sanchez-Barcelo EJ
J Pineal Res; 2008 Aug; 45(1):86-92. PubMed ID: 18298468
[TBL] [Abstract][Full Text] [Related]
40. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
